{"id":15052,"date":"2026-08-12T01:43:21","date_gmt":"2026-08-12T08:43:21","guid":{"rendered":"https:\/\/cellpeptides.com\/?post_type=product&#038;p=15052"},"modified":"2026-08-18T03:25:44","modified_gmt":"2026-08-18T10:25:44","slug":"buy-igf-1-lr3","status":"publish","type":"product","link":"https:\/\/cellpeptides.com\/hu\/product\/buy-igf-1-lr3\/","title":{"rendered":"IGF-1 LR3"},"content":{"rendered":"<h2><span style=\"font-weight: 400;\">Mi az az IGF-1 LR3?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3 teljes neve long arginine 3 insulin-like growth factor 1 (hossz\u00fa arginin 3 inzulinszer\u0171 n\u00f6veked\u00e9si faktor 1). Ez egy laborat\u00f3riumban m\u00f3dos\u00edtott szintetikus hormon, amely olyan specifikus tulajdons\u00e1gokkal rendelkezik, amelyek el\u0151ny\u00f6sebbek lehetnek a term\u00e9szetes IGF-1-n\u00e9l. A kutat\u00e1si megbesz\u00e9l\u00e9sek gyakran eml\u00edtik a szubkut\u00e1n bead\u00e1st ellen\u0151rz\u00f6tt vizsg\u00e1lati protokollokhoz, amelyet a kezel\u00e9si id\u0151vel legal\u00e1bb megegyez\u0151 hossz\u00fas\u00e1g\u00fa sz\u00fcnet k\u00f6vet a tolerancia megel\u0151z\u00e9se \u00e9rdek\u00e9ben.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Hogyan m\u0171k\u00f6dik az IGF-1 LR3?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">A vizsg\u00e1lati modellekben, amint az IGF-1 LR3 k\u00f6t\u0151dik az IGF-1 receptorokhoz, a k\u00e9t jel\u00e1tviteli \u00fat egyik\u00e9n esem\u00e9nyek sorozata aktiv\u00e1l\u00f3dik. A feh\u00e9rjeszint\u00e9zist a PI3-\u00fatvonal szab\u00e1lyozza, amelyben az IGF-1 LR3-at olyan kaszk\u00e1d serkent\u00e9se szempontj\u00e1b\u00f3l vizsg\u00e1lj\u00e1k, amely edz\u00e9s ut\u00e1n t\u00f6bb izomfeh\u00e9rje kialakul\u00e1s\u00e1t eredm\u00e9nyezheti. Ezt a v\u00e1zizomzat szatellitsejtjeinek aktiv\u00e1l\u00e1s\u00e1val \u00e9ri el, amelyek mioblasztokk\u00e1 differenci\u00e1l\u00f3dnak, hogy \u00faj izomrostokat hozzanak l\u00e9tre, n\u00f6vesztve \u00e9s regener\u00e1lva az izmot.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Mivel az IGF-1 LR3 egy inzulinszer\u0171 n\u00f6veked\u00e9si faktor, a szervezetben kifejtett inzulinszer\u0171 aktivit\u00e1s\u00e1t is vizsg\u00e1lj\u00e1k. Befoly\u00e1solhatja az izmok t\u00e1panyagfelv\u00e9tel\u00e9t, lehet\u0151v\u00e9 t\u00e9ve, hogy a sejtek t\u00f6bb gl\u00fck\u00f3zt \u00e9s aminosavat vegyenek fel.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Az IGF-1 LR3 felhaszn\u00e1l\u00e1si ter\u00fcletei<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3-at a kutat\u00e1si kontextusban a teljes\u00edtm\u00e9nnyel, az \u00f6reged\u00e9ssel \u00e9s a test\u00f6sszet\u00e9tel mechanizmusaival kapcsolatban t\u00e1rgyalj\u00e1k. Ezek a k\u00f6vetkez\u0151k:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Izomregener\u00e1ci\u00f3 \u2013 Kutat\u00e1si modellekben a peptidet a feh\u00e9rjeszint\u00e9zis szempontj\u00e1b\u00f3l vizsg\u00e1lj\u00e1k, ami edz\u00e9s ut\u00e1n nagyobb izomn\u00f6veked\u00e9shez vezethet.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">T\u00e1panyag-ell\u00e1t\u00e1s \u2014 A kutat\u00f3k az IGF-1 LR3-at egy m\u00e1sik m\u00f3don is vizsg\u00e1lj\u00e1k, m\u00e9gpedig azon hat\u00e9konys\u00e1g r\u00e9v\u00e9n, amellyel a t\u00e1panyagok el\u00e9rik az izomsejteket.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zs\u00edr\u00e9veszt\u00e9s \u2013 Az IGF-1 LR3-at az anyagcser\u00e9re gyakorolt hat\u00e1sai miatt kutatj\u00e1k. Mivel az izomfejleszt\u00e9ssel kapcsolatban is vizsg\u00e1lj\u00e1k, a kutat\u00f3k azt \u00e9rt\u00e9kelik, hogy befoly\u00e1solhatja-e a zs\u00edranyagcser\u00e9t a sov\u00e1ny izomt\u00f6meg meg\u0151rz\u00e9se mellett.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Atl\u00e9tikai regener\u00e1ci\u00f3 \u2013 A peptidn\u00e9l a sz\u00f6vetek gy\u00f3gyul\u00e1s\u00e1t \u00e9s regener\u00e1ci\u00f3j\u00e1t vizsg\u00e1lj\u00e1k, bele\u00e9rtve az izmokat, inakat \u00e9s szalagokat. Ez a kutat\u00e1s a f\u00e1jdalmat, a gyullad\u00e1st, a regener\u00e1ci\u00f3s id\u0151t \u00e9s a s\u00e9r\u00fcl\u00e9si modelleket veszi g\u00f3rcs\u0151 al\u00e1.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Sejtszint\u0171 gy\u00f3gyul\u00e1s \u2013 Az IGF-1 LR3-at az \u00f6reged\u00e9sbiol\u00f3giai \u00e9s a l\u00e1gyr\u00e9sz-s\u00e9r\u00fcl\u00e9si modellekkel kapcsolatos kutat\u00e1sok kontextus\u00e1ban t\u00e1rgyalj\u00e1k, nem pedig j\u00f3v\u00e1hagyott eszt\u00e9tikai vagy regener\u00e1ci\u00f3s megold\u00e1sk\u00e9nt.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 vs. norm\u00e1l IGF-1<\/span><\/h2>\n<p><a href=\"https:\/\/medlineplus.gov\/lab-tests\/igf-1-insulin-like-growth-factor-1-test\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">IGF-1<\/span><\/a><span style=\"font-weight: 400;\"> egy a m\u00e1j \u00e1ltal termelt hormon, amelyet a v\u00e9r\u00e1ramba bocs\u00e1tanak ki a n\u00f6veked\u00e9s \u00e9s az anyagcsere szab\u00e1lyoz\u00e1sa \u00e9rdek\u00e9ben. Az IGF-1 LR3 egy m\u00f3dos\u00edtott v\u00e1ltozat, amely olyan szerkezeti v\u00e1ltoztat\u00e1sokkal rendelkezik, amelyek cs\u00f6kkentik az inzulin-szer\u0171 n\u00f6veked\u00e9si faktorokat megk\u00f6t\u0151 feh\u00e9rj\u00e9kkel (IGFBP-k) szembeni k\u00f6t\u0151feh\u00e9rje-affinit\u00e1s\u00e1t, \u00edgy a term\u00e9szetes IGF-1-n\u00e9l tart\u00f3sabb hat\u00e1st fejt ki.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3 eset\u00e9ben a harmadik aminosav glutaminsav helyettarginin, \u00e9s a peptid N-termin\u00e1lis\u00e1n 13 tov\u00e1bbi aminosav tal\u00e1lhat\u00f3. Ezek a k\u00fcl\u00f6nbs\u00e9gek azt jelentik, hogy az IGF-1 receptor agonist\u00e1ja, de bizonyos el\u0151ny\u00f6kkel rendelkezik, bele\u00e9rtve az IGF-1-hez k\u00e9pest h\u00e1romszoros hat\u00e9konys\u00e1got. Felez\u00e9si ideje is 20 \u00e9s 30 \u00f3ra k\u00f6z\u00f6tti \u2013 ami sokkal hosszabb, mint a term\u00e9szetes hormon 12\u201315 \u00f3r\u00e1ja \u2013, \u00edgy a term\u00e9szetes IGF-1-n\u00e9l tart\u00f3sabb hat\u00e1st fejt ki. V\u00e9g\u00fcl, az extra aminosavainak k\u00f6sz\u00f6nhet\u0151en az IGF-1 LR3 jobb metabolikus stabilit\u00e1st biztos\u00edt.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">M\u00e1s sz\u00f3val az IGF-1 LR3-ban l\u00e9v\u0151 m\u00f3dos\u00edt\u00e1sok n\u00f6velik a izomfejl\u0151d\u00e9sre \u00e9s a sz\u00f6vetregener\u00e1ci\u00f3ra ir\u00e1nyul\u00f3 kutat\u00e1si potenci\u00e1lj\u00e1t, ami a peptidet hasznoss\u00e1 teszi eszt\u00e9tikai \u00e9s atl\u00e9tikai kutat\u00e1si modellek sz\u00e1m\u00e1ra.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 vs. IGF-1 DES<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 m\u00e1sik m\u00f3dosul\u00e1sa az inzulin szer\u0171 n\u00f6veked\u00e9si faktor 1 del\u00e9ci\u00f3ja (1-3), amelyet \u00e1ltal\u00e1ban IGF-1 DES-k\u00e9nt r\u00f6vid\u00edtenek. Az IGF-1 LR3-hoz hasonl\u00f3an ez is egy szintetikus peptid, amelyet \u00fagy hoztak l\u00e9tre, hogy fokozza a term\u00e9szetes IGF-1 el\u0151nyeit. Az IGF-1 DES eset\u00e9ben ezt az els\u0151 h\u00e1rom N-termin\u00e1lis aminosav hozz\u00e1ad\u00e1sok n\u00e9lk\u00fcli elt\u00e1vol\u00edt\u00e1s\u00e1val \u00e9rik el. Ezt a m\u00f3dosul\u00e1st a val\u00f3s\u00e1gban bizonyos k\u00f6rnyezetekben term\u00e9szetes m\u00f3don is felfedezt\u00e9k, ami arra utal, hogy a hormonnak bizonyos helyzetekben fontos szerepe lehet a szervezetben.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Az aminosavak elt\u00e1vol\u00edt\u00e1sa az IGF-1 DES-b\u0151l cs\u00f6kkenti a peptid IGFBP-k ir\u00e1nti k\u00f6t\u0151d\u00e9si affinit\u00e1s\u00e1t, \u00e9s n\u00f6veli az IGF-1 receptor ir\u00e1nti affinit\u00e1s\u00e1t. E tekintetben k\u00fcl\u00f6nb\u00f6zik az IGF-1 LR3-t\u00f3l, amelynek cs\u00f6kkent az affinit\u00e1sa az IGF-1 receptorhoz. Ebb\u0151l a cs\u00f6kkent affinit\u00e1sb\u00f3l ad\u00f3dik a hosszabb felez\u00e9si id\u0151.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A kutat\u00f3k a simaizom-sejt migr\u00e1ci\u00f3val \u00e9s prolifer\u00e1ci\u00f3val kapcsolatos vizsg\u00e1latokhoz jellemz\u0151en az IGF-1 DES-t v\u00e1lasztj\u00e1k a v\u00e1zizom-fejl\u0151d\u00e9s helyett, mint ahogy az az IGF-1 LR3 eset\u00e9ben t\u00f6rt\u00e9nik. A peptidnek a neurol\u00f3giai kutat\u00e1sokban is szerepe lehet, nem utols\u00f3sorban az\u00e9rt, mert term\u00e9szetesen el\u0151fordul az agjsz\u00f6vetben. R\u00f6vid felez\u00e9si ideje miatt azonban kev\u00e9sb\u00e9 alkalmas emberi alanyokon t\u00f6rt\u00e9n\u0151 tesztel\u00e9sre, mint az IGF-1 LR3.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Az IGF-1 LR3 adagol\u00e1si protokoljai a kutat\u00e1sban, a biohackingben \u00e9s a Reddit-besz\u00e1mol\u00f3kban<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3 jelenleg nem rendelkezik FDA-j\u00f3v\u00e1hagy\u00e1ssal, ami azt jelenti, hogy a alkalmaz\u00e1sa k\u00eds\u00e9rleti jelleg\u0171, \u00e9s a kutat\u00e1sra korl\u00e1toz\u00f3dik. Mint minden n\u00f6veked\u00e9si peptid eset\u00e9ben, a kutat\u00e1si protokolldknak sz\u00e1molniuk kell adagol\u00e1ssal \u00e9s a k\u00e1ros metabolikus hat\u00e1sokkal.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">K\u00f6zz\u00e9tett kutat\u00e1si protokollok<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A publik\u00e1lt kutat\u00e1sok azt vizsg\u00e1lj\u00e1k, hogy az IGF-1 LR3 alkalmas lehet-e a tiszta izomzatra, a zs\u00edmetabolizmusra vagy az \u00f6reged\u00e9sbiol\u00f3gi\u00e1ra f\u00f3kusz\u00e1l\u00f3 modellekhez. K\u00fcl\u00f6n\u00f6sen n\u00e9pszer\u0171 azon kutat\u00f3k k\u00f6r\u00e9ben, akik m\u00e1r futtatnak vizsg\u00e1latokat n\u00f6veked\u00e9si hormon (GH) szekretag\u00f3gokkal.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A peptidet haszn\u00e1l\u00f3 kutat\u00f3k protokollokat dolgoztak ki m\u00e1sok sz\u00e1m\u00e1ra, amelyeket k\u00f6vetni lehet a j\u00f6v\u0151beli, ellen\u0151rz\u00f6tt vizsg\u00e1latokban:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A kutat\u00e1si protokolloknak id\u0151szakosan ellen\u0151rizni\u00fck kell a v\u00e9rcukorszintet a hipoglik\u00e9mia lehet\u0151s\u00e9ge miatt, mivel a peptid hat\u00e1s\u00e1ra t\u00f6bb izomsejt vehet fel gl\u00fck\u00f3zt a v\u00e9r\u00e1ramb\u00f3l.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A besz\u00e1mol\u00f3k szerinti kutat\u00e1s-orient\u00e1lt protokollok 20 mcg \u00e9s 30 mcg k\u00f6z\u00f6tti kezd\u0151 d\u00f3zist \u00edrnak le, amely egy-k\u00e9t h\u00e9t ut\u00e1n 30 mcg \u00e9s 50 mcg k\u00f6z\u00f6tti \u00e9rt\u00e9kre emelkedik. B\u00e1r egyes tanulm\u00e1nyok ak\u00e1r 100 mcg-os d\u00f3zisokat is alkalmaztak, ezek nem tal\u00e1lt\u00e1k, hogy ez a fokozott kock\u00e1zattal ar\u00e1nyos el\u0151ny\u00f6kh\u00f6z vezetne.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Az IGF-1 LR3 bead\u00e1sa kutat\u00e1si k\u00f6rnyezetben a praktikum okai miatt gyakran szubkut\u00e1n t\u00f6rt\u00e9nik. B\u00e1r egyes kutat\u00f3k intramuszkul\u00e1ris injekci\u00f3kat alkalmaztak a nagyobb helyi hipertr\u00f3fia el\u00e9r\u00e9s\u00e9nek rem\u00e9ny\u00e9ben, nincs egy\u00e9rtelm\u0171 bizony\u00edt\u00e9k arra, hogy ez hat\u00e9kony lenne.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A legt\u00f6bb protokoll szerint a kutat\u00f3k az edz\u00e9s ut\u00e1ni id\u0151szakra \u00fctemezik a peptid adagol\u00e1s\u00e1t, mivel a testmozg\u00e1s fokozza az IGF-1 receptorok expresszi\u00f3j\u00e1t \u00e9s n\u00f6veli a szatellitsejtek \u00e9rz\u00e9kenys\u00e9g\u00e9t.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">A receptor deszenzibiliz\u00e1ci\u00f3 \u2013 amely sor\u00e1n a peptid m\u00e1r nem fejt ki semmilyen hat\u00e1st \u2013 megel\u0151z\u00e9se \u00e9rdek\u00e9ben a kutat\u00e1si protokolok gyakran alkalmaznak ciklusos adagol\u00e1st. A tipikus k\u00eds\u00e9rleti protokoll h\u00e1rom vagy n\u00e9gy h\u00e9t (vagy ak\u00e1r csak kett\u0151), amelyet legal\u00e1bb n\u00e9gy hetes sz\u00fcnet k\u00f6vet.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Biohacking \u00e9s Reddit-besz\u00e1mol\u00f3k<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Besz\u00e1mol\u00f3k \u00e9rkeztek az IGF-1 LR3-mal v\u00e9gzett \u00f6nk\u00eds\u00e9rletez\u00e9sr\u0151l, mint gyors megold\u00e1sr\u00f3l a fogy\u00e1sra, izomt\u00f6meg-n\u00f6vel\u00e9sre vagy mindkett\u0151re. Mivel az IGF-1 LR3 nem rendelkezik FDA-j\u00f3v\u00e1hagy\u00e1ssal, azt kiz\u00e1r\u00f3lag kutat\u00e1si c\u00e9llal, ellen\u0151rz\u00f6tt esetekben szabad kezelni, ahol a alanyok a peptidet megfelel\u0151 edz\u00e9stervbe \u00e9s megfelel\u0151 \u00e9trendbe illesztik be.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A biohacking a h\u00edrek szerint eredm\u00e9nyezett<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9597049\/\" target=\"_blank\" rel=\"noopener\"> <span style=\"font-weight: 400;\">mell\u00e9khat\u00e1sok<\/span><\/a><span style=\"font-weight: 400;\"> bele\u00e9rtve:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hipoglik\u00e9mia<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Idegbecs\u00edp\u0151d\u00e9s<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">\u00cdz\u00fcleti f\u00e1jdalom<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">V\u00edzvisszatart\u00e1s<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">A standard protokollok k\u00f6vet\u00e9se \u00e9s annak biztos\u00edt\u00e1sa, hogy egy kutat\u00f3 fel\u00fcgyelje a alanyokat, seg\u00edt cs\u00f6kkerni a jelentett mell\u00e9khat\u00e1sokat a ellen\u0151rz\u00f6tt kutat\u00e1si k\u00f6rnyezetben.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Kinek kell ker\u00fclnie az IGF-1 LR3-at?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3-expoz\u00edci\u00f3val \u2013 k\u00fcl\u00f6n\u00f6sen hossz\u00fa t\u00e1von \u2013 \u00f6sszef\u00fcgg\u0151 f\u0151bb kock\u00e1zatok k\u00f6z\u00e9 tartozik az inzulinrezisztencia \u00e9s a mitog\u00e9n hat\u00e1sok. A peptid kock\u00e1zatot jelenthet a r\u00e1kos megbeteged\u00e9ssel vagy emelkedett PSA-szinttel k\u00fczd\u0151 szem\u00e9lyek sz\u00e1m\u00e1ra amiatt, hogy v\u00e1logat\u00e1s n\u00e9lk\u00fcl serkenti a sejtn\u00f6veked\u00e9st.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ezenk\u00edv\u00fcl a profi sportol\u00f3knak nem szabad haszn\u00e1lniuk az IGF-1 LR3-at, mivel az be van tiltva a sportban.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Elk\u00e9sz\u00edt\u00e9s \u00e9s t\u00e1rol\u00e1s<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3 sz\u00e1raz por form\u00e1j\u00e1ban, vagyis liofiliz\u00e1lt form\u00e1ban \u00e9rkezik. Ebben a form\u00e1ban -20 C-os fagyaszt\u00f3ban, vagy szobah\u0151m\u00e9rs\u00e9kleten, h\u0171v\u00f6s, s\u00f6t\u00e9t helyen kell t\u00e1rolni.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kutat\u00e1si felhaszn\u00e1l\u00e1s el\u0151tt az IGF-1 LR3-at bakteriosztatikus v\u00edzzel kell rekonstitu\u00e1lni. Ebben a kevert form\u00e1ban csak h\u0171t\u00e9st ig\u00e9nyel (h\u0171tve a bekever\u00e9st\u0151l sz\u00e1m\u00edtva legfeljebb 4 h\u00e9tig haszn\u00e1lhat\u00f3 fel). A peptid szerkezet\u00e9nek meg\u0151rz\u00e9se \u00e9rdek\u00e9ben fontos elker\u00fclni az \u00fcvegcse t\u00fal er\u0151s r\u00e1z\u00e1s\u00e1t a kezel\u00e9s el\u0151tt.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 Gyakori K\u00e9rd\u00e9sek<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Mi\u00e9rt er\u0151sebb az IGF-1 LR3 a term\u00e9szetes IGF-1-n\u00e9l?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Az IGF-1 LR3 sokkal hosszabb felez\u00e9si ideje id\u0151t ad a szintetikus hormonnak arra, hogy nagyobb hat\u00e1st fejtsen ki a vizsg\u00e1lati modellekben. A r\u00f6vid hat\u00e1s\u00fa IGF-1 nem marad meg el\u00e9g ideig ahhoz, hogy ilyen jelent\u0151s feh\u00e9rjeszint\u00e9zishez \u00e9s szatellitsejt-aktiv\u00e1ci\u00f3hoz vezessen a gy\u00f3gyul\u00e1s, valamint a t\u00e1panyag-megoszt\u00e1s ter\u00e9n v\u00e9gzett zs\u00edri-anyagcsere-kutat\u00e1sokban.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Mennyi ideig vizsg\u00e1lhat\u00f3 az IGF-1 LR3 egy protokollban?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A kutat\u00e1s-orient\u00e1lt protokollok gyakran legfeljebb n\u00e9gy h\u00e9tig vizsg\u00e1lj\u00e1k az IGF-1 LR3-at, amelyet legal\u00e1bb n\u00e9gyhetes sz\u00fcnet k\u00f6vet. Ez a ciklus fenntartja a receptorok \u00e9rz\u00e9kenys\u00e9g\u00e9t, \u00e9s azt jelenti, hogy a peptid tov\u00e1bbra is kifejti hat\u00e1s\u00e1t. A kutat\u00f3k meg\u00e1llap\u00edthatj\u00e1k, hogy a alanyoknak csak az edz\u00e9snapokon szabad megkapniuk a peptidet, b\u00e1r egyesek olyan protokollt is be\u00e1ll\u00edthatnak, amely pihen\u0151napokon egy adagot tartalmaz lefekv\u00e9s el\u0151tt.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">J\u00f3l m\u0171k\u00f6dik az IGF-1 LR3 m\u00e1s peptidekkel?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Gyakori, hogy a kutat\u00f3k az IGF-1 LR3-at m\u00e1s peptidekkel, k\u00fcl\u00f6n\u00f6sen a hasonl\u00f3 tulajdons\u00e1g\u00faakkal egy\u00fctt vonj\u00e1k be a vizsg\u00e1latokba, mint p\u00e9ld\u00e1ul:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">BPC-157 \u2014 Gyullad\u00e1sos \u00e9s sz\u00f6vetregener\u00e1ci\u00f3s modellekben vizsg\u00e1lt\u00e1k, k\u00fcl\u00f6n\u00f6sen edz\u00e9s vagy l\u00e1gyr\u00e9sz-s\u00e9r\u00fcl\u00e9s ut\u00e1n.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">TB-500 \u2013 Egy m\u00e1sik gy\u00f3gy\u00edt\u00f3 peptid, amelyet az izmok \u00e9s inak s\u00e9r\u00fcl\u00e9seinek regener\u00e1ci\u00f3j\u00e1ra vizsg\u00e1lnak.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CJC-1295 ipamorelinnal \u2013 K\u00e9t n\u00f6veked\u00e9si hormon szekretag\u00f3g, amelyeket az IGF-1 LR3-mal egy\u00fctt vizsg\u00e1lnak az izomfejleszt\u00e9s, a s\u00falycs\u00f6kken\u00e9s vagy az \u00f6reged\u00e9sbiol\u00f3gia ter\u00fclet\u00e9n, a term\u00e9szetes hormontermel\u00e9s stimul\u00e1l\u00e1s\u00e1n kereszt\u00fcl.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Mikor sz\u00e1molnak be a kutat\u00f3k az IGF-1 LR3 protokollok eredm\u00e9nyeir\u0151l?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Kutat\u00f3k arr\u00f3l sz\u00e1moltak be, hogy az IGF-1 LR3 els\u0151 ciklusa ut\u00e1n k\u00f6r\u00fclbel\u00fcl k\u00e9t-h\u00e1rom h\u00e9ttel l\u00e1that\u00f3 v\u00e1ltoz\u00e1sok tapasztalhat\u00f3k izomn\u00f6veked\u00e9s ter\u00e9n.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">Hivatkoz\u00e1sok<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">1. Az inzulinszer\u0171 n\u00f6veked\u00e9si faktor-I anal\u00f3gj\u00e1nak m\u00e9r\u00e9se a v\u00e9rplazm\u00e1ban egy \u00faj immunszorbens enzimassay (ELISA) seg\u00edts\u00e9g\u00e9vel \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9582496\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/9582496\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">2. A hossz\u00fa lefoly\u00e1s\u00fa R3 inzulinszer\u0171 n\u00f6veked\u00e9si faktor-I (IGF-I) inf\u00fazi\u00f3 serkenti a szervek n\u00f6veked\u00e9s\u00e9t, de cs\u00f6kkenti a plazma IGF-I-, IGF-II- \u00e9s IGF-k\u00f6t\u0151feh\u00e9rje-koncentr\u00e1ci\u00f3j\u00e1t a tengerimalacban <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7561636\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/7561636\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">3. A foszfatidilinozitol-3-kin\u00e1z \u00e9s a p70 s6 kin\u00e1z r\u00e9szt vesz a v\u00e1zizomzat feh\u00e9rjeturnus\u00e1nak szab\u00e1lyoz\u00e1s\u00e1ban az inzulin \u00e9s az inzulinhoz hasonl\u00f3 1-es n\u00f6veked\u00e9si faktor \u00e1ltal <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8828461\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/8828461\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">4. Az IGF-1-induk\u00e1lt v\u00e1zizom-miotubusz hipertr\u00f3fia k\u00f6zvet\u00edt\u00e9se a PI(3)K\/Akt\/mTOR \u00e9s PI(3)K\/Akt\/GSK3 \u00fatvonalak \u00e1ltal \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11715022\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/11715022\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">5. Az inzulinhoz hasonl\u00f3 n\u00f6veked\u00e9si faktor-I meghosszabb\u00edtja a v\u00e1zizomzat szatellitsejtjeinek in vitro replikat\u00edv \u00e9lettartam\u00e1t a G1\/S sejtciklus el\u0151rehalad\u00e1s\u00e1nak fokoz\u00e1sa r\u00e9v\u00e9n, a foszfatid\u00fclinozitol-3\u2032-kin\u00e1z\/Akt jel\u00e1tviteli \u00fatvonal aktiv\u00e1l\u00e1s\u00e1n kereszt\u00fcl \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10962000\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/10962000\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">6. A gl\u00fck\u00f3zstimul\u00e1lt inzulinszekr\u00e9ci\u00f3 cs\u00f6kken\u00e9se egyhetes IGF-1 inf\u00fazi\u00f3t k\u00f6vet\u0151en a vemhess\u00e9g v\u00e9g\u00e9n l\u00e9v\u0151 magzati juhokban egy intrinszik szigeteket \u00e9rint\u0151 defektusnak tudhat\u00f3 be \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33938236\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33938236\/<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p><span style=\"font-weight: 400;\">A preklinikai \u00e9s laborat\u00f3riumi vizsg\u00e1latokban a kutat\u00f3k azt vizsg\u00e1lt\u00e1k, hogy<strong> IGF-1 LR3<\/strong> mint egy peptid, amelynek potenci\u00e1lja van az izomn\u00f6veked\u00e9s fokoz\u00e1s\u00e1ra, az edz\u00e9s ut\u00e1ni fel\u00e9p\u00fcl\u00e9si id\u0151 felgyors\u00edt\u00e1s\u00e1ra, a zs\u00edranyagcsere befoly\u00e1sol\u00e1s\u00e1ra \u00e9s a b\u0151r regener\u00e1ci\u00f3j\u00e1nak t\u00e1mogat\u00e1s\u00e1ra. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ezek a kutat\u00e1si ter\u00fcletek oda vezettek, hogy a peptid n\u00e9pszer\u0171 opci\u00f3v\u00e1 v\u00e1lt a teljes\u00edtm\u00e9nyn\u00f6vel\u00e9ssel, a s\u00falyveszt\u00e9ssel \u00e9s az \u00f6reged\u00e9sg\u00e1tl\u00e1ssal kapcsolatos t\u00e9m\u00e1kban.<\/span><\/p>","protected":false},"featured_media":15057,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[61,45,47,44],"product_tag":[],"class_list":["post-15052","product","type-product","status-publish","has-post-thumbnail","product_cat-bestsellers","product_cat-peptides-for-fat-metabolism-research","product_cat-igf-1-growth-hormone-research","product_cat-peptides-for-muscle-growth-research","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buy IGF-1 LR3 (99% Purity) - CellPeptides<\/title>\n<meta name=\"description\" content=\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/hu\/product\/buy-igf-1-lr3\/\" \/>\n<meta property=\"og:locale\" content=\"hu_HU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy IGF-1 LR3 (99% Purity) - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/hu\/product\/buy-igf-1-lr3\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-18T10:25:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Becs\u00fclt olvas\u00e1si id\u0151\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 perc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\",\"url\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\",\"name\":\"Buy IGF-1 LR3 (99% Purity) - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"datePublished\":\"2026-08-12T08:43:21+00:00\",\"dateModified\":\"2026-08-18T10:25:44+00:00\",\"description\":\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb\"},\"inLanguage\":\"hu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"width\":1200,\"height\":1200,\"caption\":\"IGF-1 LR3 1mg_mockup\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/cellpeptides.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IGF-1 LR3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"hu\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IGF-1 LR3 (99% tisztas\u00e1g\u00fa) v\u00e1s\u00e1rl\u00e1sa \u2013 CellPeptides","description":"V\u00e1s\u00e1roljon IGF-1 LR3-at, amelyet n\u00f6veked\u00e9si faktor \u00e9s izomhipertr\u00f3fia c\u00e9lj\u00e1b\u00f3l fejlesztettek ki. 99% tisztas\u00e1g\u00fa, HPLC-vel ellen\u0151rz\u00f6tt. Kattintson ide, hogy m\u00e9g ma megrendelje!.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/hu\/product\/buy-igf-1-lr3\/","og_locale":"hu_HU","og_type":"article","og_title":"Buy IGF-1 LR3 (99% Purity) - CellPeptides","og_description":"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.","og_url":"https:\/\/cellpeptides.com\/hu\/product\/buy-igf-1-lr3\/","og_site_name":"CellPeptides","article_modified_time":"2026-08-18T10:25:44+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Becs\u00fclt olvas\u00e1si id\u0151":"8 perc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/","url":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/","name":"IGF-1 LR3 (99% tisztas\u00e1g\u00fa) v\u00e1s\u00e1rl\u00e1sa \u2013 CellPeptides","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage"},"image":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage"},"thumbnailUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","datePublished":"2026-08-12T08:43:21+00:00","dateModified":"2026-08-18T10:25:44+00:00","description":"V\u00e1s\u00e1roljon IGF-1 LR3-at, amelyet n\u00f6veked\u00e9si faktor \u00e9s izomhipertr\u00f3fia c\u00e9lj\u00e1b\u00f3l fejlesztettek ki. 99% tisztas\u00e1g\u00fa, HPLC-vel ellen\u0151rz\u00f6tt. Kattintson ide, hogy m\u00e9g ma megrendelje!.","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb"},"inLanguage":"hu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/"]}]},{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","width":1200,"height":1200,"caption":"IGF-1 LR3 1mg_mockup"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/cellpeptides.com\/shop\/"},{"@type":"ListItem","position":3,"name":"IGF-1 LR3"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"CellPeptides","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"hu"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"CellPeptides","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product\/15052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"version-history":[{"count":0,"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product\/15052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/media\/15057"}],"wp:attachment":[{"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/media?parent=15052"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product_brand?post=15052"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product_cat?post=15052"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cellpeptides.com\/hu\/wp-json\/wp\/v2\/product_tag?post=15052"}],"curies":[{"name":"sz\u00e9p volt","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}